21.2 C
New York
Thursday, June 18, 2026

Tag: presentation

Star Equity Holdings to Present at the Noble Capital Markets Emerging Growth Virtual Conference on June 3-4

OLD GREENWICH, Conn., June 01, 2026 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR and STRRP) ("Star" or the "Company"), a diversified holding company, announced today that its management team will present and host one-on-one meetings with investors at Noble Capital Markets Emerging Growth Virtual Conference, which will take place from June 3-4, 2026.

Elliott Publishes Presentation Outlining Perspectives on Value Creation at Northern Star Resources Ltd

WEST PALM BEACH, Fla., June 2, 2026 /PRNewswire/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together hold an investment of well...

Elliott Publishes Presentation Outlining Perspectives on Value Creation at Northern Star Resources Ltd

WEST PALM BEACH, Fla., June 1, 2026 /PRNewswire/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together hold an investment of well...

Elliott Publishes Presentation Outlining Perspectives on Value Creation at Northern Star Resources Ltd

WEST PALM BEACH, Fla., June 1, 2026 /CNW/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together hold an investment of well...

Elliott Publishes Presentation Outlining Perspectives on Value Creation at Northern Star Resources Ltd

WEST PALM BEACH, Fla., June 1, 2026 /PRNewswire/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together hold an investment of well...

Elliott Publishes Presentation Outlining Perspectives on Value Creation at Northern Star Resources Ltd

WEST PALM BEACH, Fla., June 1, 2026 /PRNewswire/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together hold an investment of well...

Manufacturing PMI® at 54%; May 2026 ISM® Manufacturing PMI® Report

New Orders Growing; Production Growing; Employment Contracting; Supplier Deliveries Slowing; Raw Materials Inventories Contracting; Customers' Inventories Too Low; Prices Increasing; Imports Growing; Exports GrowingTEMPE,...

National Healthcare Properties Provides Business Updates

Growing SHOP Acquisition Pipeline
Addition to the Russell 2000 and 3000 Indexes
Presentation at Nareit’s REITweek 2026 Investor Conference

Telia Lietuva, AB presentation to investors at event ‘CEO Meets Investors’

On 1 June 2026, Giedrė Kaminskaitė-Salters, CEO of Telia Lietuva, made a presentation to investors at Nasdaq Baltic organized event CEO Meets Investors.

InterDigital to Share 6G Leadership, Potential for ISAC and Agentic AI at EuCNC & 6G Summit

At EuCNC, InterDigital will demonstrate 6G leadership in AI, ISAC, and collaborative sensing for 6G verticals, part of the SNS-JU MultiX project

ATN International, Inc. to Present and Host 1×1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026 in...

BEVERLY, Mass., May 29, 2026 (GLOBE NEWSWIRE) -- ATN International, Inc. (“ATN”, the “Company”, “we”, “us”, and “our”) (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, today announced that management will participate in the 16th Annual East Coast IDEAS Investor Conference at The Westin New York at Times Square on June 11, 2026.

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and...

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it has received clearance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to conduct GLORA-4 study (NCT06641414), a global registrational Phase III study of lisaftoclax (APG-2575), a proprietary Bcl-2 inhibitor, in combination with azacitidine (AZA), for the treatment of patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS).

Nerve Soothe Launches All-New Nerve Support Formula in 2025 Amid Surging Interest in Natural Relief Solutions

Public curiosity around nerve health is rising in 2025, with searches, podcasts, and social platforms highlighting natural approaches. Nerve Soothe enters this conversation with a formula designed around ingredient transparency, plant-based extracts, and consumer-driven expectations for wellness support.
Public curiosity around nerve health is rising in 2025, with searches, podcasts, and social platforms highlighting natural approaches. Nerve Soothe enters this conversation with a formula designed around ingredient transparency, plant-based extracts, and consumer-driven expectations for wellness support.

Summary of Baltic Horizon Fund webinar

On the 15th of August 2025, Baltic Horizon held an investor webinar where fund manager Tarmo Karotam introduced the results of Q2 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPresentation